September 29, 2016
Bioventus has appointed Michael Minogue to its board of managers.
“We are pleased to have Michael Minogue join our board as we continue to grow Bioventus,” Tony Bihl, Bioventus chief executive officer, said in a press release. “His leadership at Abiomed, bringing life changing medical technologies through development and into the health care markets globally, will be invaluable to our mission to be a global leader in orthobiologics. We look forward to working with Michael as we continue to execute on our growth strategies.”